Aug. 6 at 1:53 PM
$CORT
CORT will get to
$300 within 12 months
(1) Corcept just had the second best cancer drug launch of all time. Think about that for a minute. The cancer program alone is worth
$200/sh. Relacorilant’s mechanism applies to multiple different cancer types, so this is just the start.
(2) The shorts (who first said the cancer drug wouldn’t get approved and then said it wouldn’t sell) were caught completely off guard. They now need over
$1 billion they don’t have, to close out their position. They are in a death spiral.
(3) Because the shorts can’t unwind without sending stock north of
$200, instesd they dig a deeper hole and dump at open and dump an additional 250k shares during last 2 minutes of trading every day. They think dumping 1/4 of daily volume at close will spook people.
